Spero Therapeutics SPRO
NASDAQ SPRO
$1.17 -0.05 (-4.10%)
At close: Oct 21, 2026 · 4:00 PM EDT

Spero Therapeutics (SPRO) Current Assets (2016 - 2026)

Updated

Spero Therapeutics (SPRO) recorded Current Assets of $51.58 million in Q2 2026, down 13.2% from $59.4 million a year earlier and down 10.5% from the prior quarter.

Analysis

Spero Therapeutics (SPRO) Current Assets (2016 - 2026) Analysis & Trends

At the end of FY2025, Spero Therapeutics reported Current Assets of $67.29 million, down 37.3% from FY2024.

  • Annual Current Assets has a five-year compound annual growth rate of -13.5% (FY2020 to FY2025).
  • Across earlier years, Current Assets came in at $107.28 million in FY2024 (-18.2%), $131.21 million in FY2023 (+15.5%), $113.57 million in FY2022 (-28.1%) and $157.87 million in FY2021 (+13.5%).
  • The Q2 2026 figure is the lowest quarterly Current Assets since Q3 2017.
  • On a year-over-year basis, Current Assets has declined for seven consecutive quarters, with an average decline of 27.6% over the last eight quarters.
  • Peak year-over-year performance for Current Assets in the last five years was growth of 93.3% in Q3 2023, against a decline of 60.2% in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $57.61 million (Q1 2026), $67.29 million (Q4 2025) and $52.32 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 64.67 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 59.77 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 33.67 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 36.68 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 27.97 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.96 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 13.95 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 41.36 Bn
10 Spero Therapeutics 68.40 Mn -127.38 Mn - 51.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.58 Mn
Mar 31, 2026 57.61 Mn
Dec 31, 2025 67.29 Mn
Sep 30, 2025 52.32 Mn
Jun 30, 2025 59.40 Mn
Mar 31, 2025 74.71 Mn
Dec 31, 2024 107.28 Mn
Sep 30, 2024 131.63 Mn
Jun 30, 2024 122.22 Mn
Mar 31, 2024 140.15 Mn
Dec 31, 2023 131.21 Mn
Sep 30, 2023 102.22 Mn
Jun 30, 2023 88.35 Mn
Mar 31, 2023 101.66 Mn
Dec 31, 2022 113.57 Mn
Sep 30, 2022 52.89 Mn
Jun 30, 2022 51.95 Mn
Mar 31, 2022 132.70 Mn
Dec 31, 2021 157.87 Mn
Sep 30, 2021 131.77 Mn
API Access

Spero Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=SPRO&period=max&api_key=YOUR_API_KEY